Lv1
40 积分 2025-06-15 加入
Elucidating the mechanisms of additive effects at high concentrations on hydrophobic interaction chromatography
1个月前
已完结
Clearance of solvents and small molecule impurities in antibody drug conjugates via ultrafiltration and diafiltration operation
6个月前
已完结
CMC Regulatory Considerations for Antibody-Drug Conjugates
6个月前
已完结
Antibody–drug conjugates come of age in oncology
6个月前
已完结
“Negative” Impact: The Role of Payload Charge in the Physicochemical Stability of Auristatin Antibody–Drug Conjugates
7个月前
已完结
Homogeneous Dual-Payload Antibody-Drug Conjugates Produced by Combined Distinct Conjugation Strategies
10个月前
已完结
Dual-payload Antibody–drug Conjugates: Taking a Dual Shot
10个月前
已完结
Dual-payload ADCs move into first oncology clinical trials
10个月前
已完结
First-in-class PD-1/IL-2 bispecific antibody IBI363 in patients (Pts) with advanced immunotherapy-treated non-small cell lung cancer (NSCLC)
11个月前
已完结
IL-2Rα-biased agonist enhances antitumor immunity by invigorating tumor-infiltrating CD25+CD8+ T cells
11个月前
已完结
皖公网安备34019202002308
